Outcome measures and clinical assessment instruments in neuromuscular disease

Jeffrey Rosenfeld; Carlayne E Jackson

doi:10.1007/978-1-4614-6567-6_15

Outcome measures and clinical assessment instruments in neuromuscular disease

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter reviews issues which result from consideration of the optimal outcome measures. By its nature, the process of measurement requires reducing a dynamic process (the patient dealing with their disability) to a 2-dimensional snapshot (the patient's score at one point in time) that will be used to reflect a patient's condition. Measurement is usually an imperfect process, especially when relatively small treatment effects are expected. Multiple examples of available treatment instruments will be reviewed with an emphasis on their benefits and limitations for future use.

Original language	English (US)
Title of host publication	Neuromuscular Disorders in Clinical Practice
Publisher	Springer New York
Pages	287-326
Number of pages	40
Volume	9781461465676
ISBN (Print)	9781461465676, 1461465664, 9781461465669
DOIs	https://doi.org/10.1007/978-1-4614-6567-6_15
State	Published - Nov 1 2014
Externally published	Yes

Keywords

clinical trials
outcome measures
quality of life
sensitivity
specificity

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-1-4614-6567-6_15

Fingerprint Dive into the research topics of 'Outcome measures and clinical assessment instruments in neuromuscular disease'. Together they form a unique fingerprint.

Cite this

@inbook{a9549287979140d6b618f4ae740aca3a,

title = "Outcome measures and clinical assessment instruments in neuromuscular disease",

abstract = "This chapter reviews issues which result from consideration of the optimal outcome measures. By its nature, the process of measurement requires reducing a dynamic process (the patient dealing with their disability) to a 2-dimensional snapshot (the patient's score at one point in time) that will be used to reflect a patient's condition. Measurement is usually an imperfect process, especially when relatively small treatment effects are expected. Multiple examples of available treatment instruments will be reviewed with an emphasis on their benefits and limitations for future use.",

keywords = "clinical trials, outcome measures, quality of life, sensitivity, specificity",

author = "Jeffrey Rosenfeld and Jackson, {Carlayne E}",

year = "2014",

month = nov,

day = "1",

doi = "10.1007/978-1-4614-6567-6_15",

language = "English (US)",

isbn = "9781461465676",

volume = "9781461465676",

pages = "287--326",

booktitle = "Neuromuscular Disorders in Clinical Practice",

publisher = "Springer New York",

}

TY - CHAP

T1 - Outcome measures and clinical assessment instruments in neuromuscular disease

AU - Rosenfeld, Jeffrey

AU - Jackson, Carlayne E

PY - 2014/11/1

Y1 - 2014/11/1

N2 - This chapter reviews issues which result from consideration of the optimal outcome measures. By its nature, the process of measurement requires reducing a dynamic process (the patient dealing with their disability) to a 2-dimensional snapshot (the patient's score at one point in time) that will be used to reflect a patient's condition. Measurement is usually an imperfect process, especially when relatively small treatment effects are expected. Multiple examples of available treatment instruments will be reviewed with an emphasis on their benefits and limitations for future use.

AB - This chapter reviews issues which result from consideration of the optimal outcome measures. By its nature, the process of measurement requires reducing a dynamic process (the patient dealing with their disability) to a 2-dimensional snapshot (the patient's score at one point in time) that will be used to reflect a patient's condition. Measurement is usually an imperfect process, especially when relatively small treatment effects are expected. Multiple examples of available treatment instruments will be reviewed with an emphasis on their benefits and limitations for future use.

KW - clinical trials

KW - outcome measures

KW - quality of life

KW - sensitivity

KW - specificity

UR - http://www.scopus.com/inward/record.url?scp=84949178971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949178971&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6567-6_15

DO - 10.1007/978-1-4614-6567-6_15

M3 - Chapter

AN - SCOPUS:84949178971

SN - 9781461465676

SN - 1461465664

SN - 9781461465669

VL - 9781461465676

SP - 287

EP - 326

BT - Neuromuscular Disorders in Clinical Practice

PB - Springer New York

ER -